Mounjaro (tirzepatide) Injection isindicated for once-weekly administration as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It can be used: As monotherapy when metformin is inappropriate due to contraindication or intolerance.